POLICY WATCH
The Bitter
MedicineA proposed law
scrapping the BIFR leaves the financial sector aghast at its
interventionist tone.
By
Seetha
It
could become a classic case of the prescription being worse than the
disease. The Department of Company Affairs (DCA) is putting the finishing
touches to a Bill that will bring the curtains down on the Sick Industrial
Companies Act (SICA), 1985, and, with it, the Board of Industrial and
Financial Restructuring (BIFR) and the Appellate Authority of Industrial
and Financial Restructuring (AAIFR). But the rejoicing is muted. For, the
alternative mechanism being drawn up is perceived as an old tablet in a
new foil (See The New Prescription).
Revival and restructuring of companies
would now be handled by a National Company Law Tribunal (NCLT). And in
order to bring different agencies dealing with commercial insolvency under
one umbrella, the tribunal will also do the work of the Company Law Board
(CLB) and conduct winding up proceedings. Right now, creditors approach
the high courts and debt recovery tribunals for action against defaulting
firms, small investors knock the doors of the CLB, while the
rehabilitation of companies is handled by the BIFR, and high courts
conduct winding up proceedings when revival does not work.
In the new system, sick companies have to
register themselves with the tribunal that must consider revival as a
first option. Promoters, lenders, and other stakeholders must file their
responses to a rehabilitation package in the form of affidavits. If a
consensus proves elusive, the tribunal will lay down a scheme that will be
binding on all parties.
Banks and financial institutions (FIs) are
dismayed over the proposed law (based on the report of the V.B. Eradi
committee on the law relating to insolvency and winding up of companies).
Laments Shashi Bhojani, Deputy Managing Director, ICICI: ''This merely
renames the BIFR and burdens it with more work.'' Kishore Soni, Chief
Executive Officer of Soni Industrial Restructuring Consultants, points out
that while the BIFR merely attempted to revive dying companies, the NCLT
will have to both cure sick firms and perform the last rites. As a result,
he warns, revival and winding up of companies, each of which already take
nearly four years to complete, will only get further delayed.
It's not as if lenders are happy with the
BIFR. Burdened with over Rs 70,000 crore of non-performing assets (NPAs),
they had found this to be the biggest obstacle to recovering their money.
Here's why.
SICA insists that a sick company must
compulsorily refer itself to the BIFR. Once that's done, Section 22 of the
Act comes into operation, shielding companies from any proceedings before
any other forum. Given the painfully slow progress of cases, companies
file references under BIFR as soon as lenders filed recovery suits against
them in courts. Says K.A. Najmi, Legal Adviser to the Industrial Finance
Corporation of India (IFCI): ''The BIFR was being used solely to delay
recovery.'' Not surprisingly, of the 3,296 cases filed till December,
2000, 20 per cent were dismissed as non-maintainable.
Poor Recovery
That's more, the BIFR rarely managed to
turn around sick companies. Only 254 had been revived till December,
2000-a measly 7 per cent of the cases filed. Asserts Sumant Batra,
Secretary, Insol India, an association of insolvency lawyers and
professionals: ''The Act has been a complete disaster.''
The proposed legislation, unfortunately, is
an improvement only in one respect. While SICA defined a sick company as
one whose entire net worth has turned negative, the new law sets a 50-per
cent erosion of net worth or debt default to a certain extent as the
trigger for reference to the NCLT. This definition was first mooted in a
1997 SICA Amendment Bill that never saw the light of day and repeated in
the Eradi Committee report.
SICA's definition of sickness ensured that
companies came to BIFR when there was no hope of revival. No wonder, then,
that 25 per cent of the cases ended up as winding up cases, leaving
secured creditors high and dry. That's why the financial sector had been
insisting on debt default as the criterion of sickness. Says Soni:
''Erosion of net worth is nowhere as transparent as debt default. Fudging
accounts to feign sickness and get protection of Section 22 is common.''
Subodh Bhargava, Adviser, Eicher Group, and
member of the Eradi Committee, concedes the point but feels the two-part
definition is a good compromise. Since debt default precedes net worth
erosion, he argues, that will become the more often used criterion to
determine sickness. Economist Omkar Goswami, author of a 1993 report on
industrial sickness and corporate restructuring, fails to see the logic,
but the lending fraternity isn't kicking up too much of a fuss. Says
Bhojani: ''We are willing to live with this.''
They don't feel the same about several
other provisions that, they say, will severely limit their freedom of
operation. Take the proposal for compulsory reference for revival, though
the Eradi committee had suggested that references be made voluntary.
Explanations by the DCA that the mandatory reference would prevent
companies coming for revival only in the final stages, aren't accepted.
Points out Goswami: ''With debt default as a criterion, the number of
cases will be far, far more than what's going to BIFR.'' Goswami
reiterates a point he made in his 1993 report-that making references
voluntary will give both the company and the lenders freedom to work out a
rehabilitation package by themselves. In any case, he wonders how a 50-per
cent erosion of net worth can make government intervention compulsory.
For, technically the shareholders still have some funds available. ''The
whole concept is flawed,'' he avers.
What has left the financial sector aghast
are the proposals to give the tribunal powers to force revival schemes on
companies and creditors. The Eradi Committee had first mooted the idea,
saying the tribunal must have the power to direct the preparation of a
revival scheme ''under its supervision and for ordering financial
assistance for such a scheme from FIs/banks''. Bhargava's argument that
this was necessitated by the fact that each stakeholder invariably expect
others to make greater financial sacrifices than themselves, doesn't
convince many.
Self-Medication
The New
Prescription |
» SICA
to be repealed; BIFR, AAIFR wound up
» National
Company Law Tribunal to:
deal with insolvency and sickness; handle work of the Company Law
Board deal with winding up of companies
Sickness defined as 50 percent net worth erosion and debt default
» References
regarding incipient sickness to be mandatory
» Strict
time-limits for revival schemes and liquidation proceedings
» Parties
to revival schemes must file affidavits regarding responses
» Tribunal
can lay down own revival scheme if consensus fails
» Panels
of professional liquidators and valuers to be set up |
The Side Effects |
» Tribunal
will be bogged down with too much work
» Mandatory
reference will result in firms feigning sickness
» Lenders'
operational flexibility will be limited |
Rehabilitation, lenders point out, should
be worked out among borrowers and lenders and cannot be dictated by a
statutory body. Asserts B.D. Ushir, Executive Director (Legal) of the
Industrial Development Bank of India (IDBI): ''Let the lender decide
whether to kill the borrower or help his survival. The decision will
always be based on practical considerations.'' After all, a healthy
corporate sector is in the interest of the financial sector and it will
not do anything to endanger that.
A better alternative would have been to
sanction a scheme if lenders holding 75 per cent of the monetary value of
the secured debt agree, a provision contained in the 1997 SICA amendment
Bill and in a corporate debt restructuring mechanism currently being
formulated by the finance ministry. The statutory authority, argues Ushir,
must only be a facilitator to bring companies and creditors together.
In fact, there is a growing opinion that
rather than scrapping BIFR, it would be better to retain it in a reformed
manner, with strict time limits for each step towards revival. ''We must
give the devil his due,'' says Ushir pointing out that SICA and BIFR
helped develop expertise in formulating and packaging revival schemes.
Concurs Soni: ''The BIFR must be reformed and given a new avatar.''
Soni and Goswami suggest a system where
debt default triggers off bankruptcy proceedings and the case comes to
BIFR only if negotiations (to be completed within a month) with secured
creditors fail. After that there are deadlines for each successive step,
whether sanctioning of a revival plan or winding up a company. Proceedings
would, therefore, be completed within three months, a far cry from the
endless delays in the present system.
Both the Eradi Committee and the DCA,
however, felt that a clean break with the old system would be better. But
realising the need to speed up procedures, the proposed law sets a 180-day
deadline for the NCLT, which will have to provide a written explanation
for any delay. Few, however, expect this to be of any use, considering the
fact that the tribunal is burdened with other tasks as well.
The real solution to the messy issue of
corporate insolvency actually lies in a slew of other reforms. Like
stricter foreclosure laws, says Bharti Gupta Ramola, Executive Director of
PriceWaterhouseCoopers, so that lenders don't have to wait endlessly to
recover their dues. Unfortunately, that's missing in India.
Banks and FIs also need to be more alert
about the financial performance of their borrowers, so that they can
initiate action at the first sign of trouble. Says Ramola: ''Prudent
lenders will start talking to a company as soon as they sense imminent
default. Right now, they start talking only after default happens.'' FIs
admit laxity on their part in this matter but also point out that
government ownership hampers their freedom of operation.
Just as other outdated laws limit the
operational flexibility of companies, because of which revival plans tend
to fail. Bhargava has the last word: ''The full potential of industry can
only be realised by a whole range of other reforms.'' Amen to that.
-Additional
reporting by Ashish Gupta
|